+ Include: 4 videos + 1 pdf, size: 66 GB
+ Target Audience: pathologists, histopathologists, gastrointestinal pathologists
+ Information:
The London GI PATHOLOGY Update 2025 is again a hybrid event, expanding further to four full days. It will take place from Tuesday 29th April to Friday 2nd May 2025 at the Barbican Centre, London.
Tuesday and Wednesday’s talks will deal mainly with Gastrointestinal Pathology while Friday’s will focus on Liver/Pancreatobiliary Disease. The programme on Thursday covers a mixture of both. You can choose to attend in person or to watch live streams or recordings.
The faculty includes previous participants as well as many new speakers from the UK, Europe and the USA. As always, they are enthusiastic experts who have a strong interest in education and deliver high quality lectures regularly.
The event concentrates on Diagnostic Cellular Pathology, and the talks will include updates on new developments and concepts to complement existing knowledge.
Anyone who reports gastrointestinal and/or hepatopancreatobiliary pathology will benefit from attending the event. Please register to take part in an enjoyable and informative congress with top quality experts from around the world.
The 7th London GI Pathology Update 2025, hosted by The Royal College of Pathologists, is designed for professionals who report or specialize in digestive disease pathology. The target audience includes:
- Histopathologists and gastrointestinal pathologists
- Consultants and trainees in pathology
- Biomedical scientists involved in GI specimen analysis
- Academic researchers in gastrointestinal, liver, and pancreatobiliary pathology
- Healthcare professionals seeking CPD-accredited updates in GI pathology
The event features expert-led lectures on topics like colorectal neoplasia, liver pathology, and drug-induced GI disorders, making it especially valuable for those aiming to stay current with diagnostic challenges and evolving classifications
+ Topics:
*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below
LGIPath-2025-Programme-02.pdf
April 29.mp4
April 30.mp4
May 1.mp4
May 2.mp4
* Detail:
Tuesday 29 April – Drugs, inflammation, and lower GI neoplasmsRegistration and Access to the Barbican Centre – Frobisher Auditorium 1 from 8.30am | |||
Time | Speaker | Country | |
09.15-09.20 | Introduction | Roger Feakins | UK |
09.20-10.00 | Drugs and the lower GI tract | Roger Feakins | UK |
10.00-10.40 | Drugs and the liver | Yoh Zen | UK |
10.40-11.10 | Coffee Break | ||
11.10-11.50 | Diagnosis & differential diagnosis of inflammatory bowel disease | Francesca Rosini | I |
11.50-12.30 | Ischaemic bowel: how and what to report | Newton Wong | UK |
12.30-13.30 | Lunch Break | ||
13.30-14.10 | An update on anal neoplasia | Newton Wong | UK |
14.10-14.55 | Appendix neoplasms: basic considerations | Norman Carr | UK |
14.55-15.25 | Coffee Break | ||
15.25-16.00 | Appendix neoplasms: difficult situations | Norman Carr | UK |
16.00-16.40 | Colorectal neoplasia for pathologists | Daniela Allende | US |
16.40-16.45 | Closing Remarks |
Wednesday 30 April – Upper GI tract disease and wider considerationsRegistration and Access to the Barbican Centre – Frobisher Auditorium 1 from 8.30am | |||
Time | Speaker | Country | |
09.15-09.20 | Introduction | Roger Feakins | UK |
09.20-10.00 | How to approach oesophageal and gastric inflammatory lesions | Daniela Allende | US |
10.00-10.40 | Coeliac disease and its mimics | Francesca Rosini | I |
10.40-11.10 | Coffee Break | ||
11.10-11.50 | Polyps of the upper GI tract | Elizabeth Montgomery | US |
11.50-12.30 | Autoimmune disorders and immune deficiency in the GI tract | Manuel Rodriguez-Justo | UK |
12.30-13.30 | Lunch Break | ||
13.30-14.10 | Molecular testing in colorectal and other GI cancers | Manuel Rodriguez-Justo | UK |
14.10-15.00 | Mast cell, histiocytic, & lymphoid neoplastic infiltrates in the GI tract: selected diagnostic problems | Jason Hornick | US |
15.00-15.30 | Coffee Break | ||
15.30-16.10 | Making sense of upper gastrointestinal tract cancer | Elizabeth Montgomery | US |
16.10-16.40 | Liver pathology in inflammatory GI diseases | Robert Goldin | UK |
16.40-16.45 | Closing Remarks | ||
RECORDINGS ONLY – Jakob Nikolas Kather D • New AI Tools – How Will Technology Change the Picture? • AI for pathology image analysis in GI cancer |
Thursday 1 May – Infections and neoplasia of GI and HPB systemsRegistration and Access to the Barbican Centre – Frobisher Auditorium 1 from 8.30am | |||
Time | Speaker | Country | |
09.15-09.20 | Introduction | Roger Feakins | UK |
09.20-10.00 | Parasitic, protozoal, and fungal infections of the GI tract and liver | Laura Lamps | US |
10.00-10.40 | Barrett’s oesophagus in 2025 – the role of the pathologist | John Hart | US |
10.40-11.10 | Coffee Break | ||
11.10-11.55 | Infectious mimics of other intestinal diseases | Laura Lamps | US |
11.55-12.30 | Neuroendocrine neoplasms: a practical approach/cases | Elizabeth Montgomery | US |
12.30-13.30 | Lunch Break | ||
13.30-14.20 | Mesenchymal neoplasms of the GI tract: a contemporary update | Jason Hornick | US |
14.20-14.55 | Metastases to the liver in clinical practice | Yoh Zen | UK |
14.55-15.25 | Coffee Break | ||
15.25-15.55 | Case based HPB presentation | Yoh Zen | UK |
15.55-16.40 | Problematic aspects of diagnostic pathology of the gallbladder | Volkan Adsay | TR |
16.40-16.45 | Closing Remarks |
Friday 2 May – Liver and pancreatobiliary pathologyRegistration and Access to the Barbican Centre – Frobisher Auditorium 1 from 8.30am | |||
Time | Speaker | Country | |
09.15-09.20 | Introduction | Roger Feakins | UK |
09.20-10.00 | Autoimmune diseases and overlap syndromes of the liver | John Hart | US |
10.00-10.40 | Acute hepatitis | Rob Goldin | UK |
10.40-11.10 | Coffee Break | ||
11.10-11.50 | Liver biopsy in steatotic liver disease | Rob Goldin | UK |
11.50-12.30 | Benign nodules of the liver: a practical approach to assessment | Valerie Paradis | F |
12.30-13.30 | Lunch Break | ||
13.30-14.10 | Vascular disorders in liver biopsies | John Hart | US |
14.10-14.55 | Challenges in diagnosis and reporting of pancreatobiliary adenocarcinomas | Volkan Adsay | TR |
14.55-15.25 | Coffee Break | ||
15.25-16.05 | Primary malignancy of the liver | Valerie Paradis | F |
16.05-16.40 | Macroscopic sampling of Whipple specimens: implications for management | Volkan Adsay | TR |
16.40-16.45 | Closing Remarks | Roger Feakins | UK |